Amfetamin og psykose
- Prosjektnummer
- 911617
- Ansvarlig person
- Else-Marie Løberg
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Strategiske midler - rusforskning
- Helsekategori
- Mental Health
- Forskningsaktivitet
- 1. Underpinning, 2. Aetiology
The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement.
PLoS One 2016;11(12):e0167390. Epub 2016 des 15
PMID: 27977720
Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
Psychol Med 2016 Nov;46(15):3127-3136. Epub 2016 aug 18
PMID: 27534999
The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis.
BMC Psychiatry 2016 Mar 14;16():60. Epub 2016 mar 14
PMID: 26973142
Patient satisfaction after acute admission for psychosis.
Nord J Psychiatry 2016 Jul;70(5):321-8. Epub 2016 jan 11
PMID: 26750532
Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
Schizophr Res 2016 Jan;170(1):217-21. Epub 2015 des 9
PMID: 26682958
Suicidality in schizophrenia spectrum disorders: the relationship to hallucinations and persecutory delusions.
Eur Psychiatry 2015 Oct;30(7):830-6. Epub 2015 sep 25
PMID: 26443050
Prevalence of auditory hallucinations in Norwegian adolescents: results from a population-based study.
Scand J Psychol 2015 Aug;56(4):391-6. Epub 2015 mai 12
PMID: 25968251
Glutamate as a mediating transmitter for auditory hallucinations in schizophrenia: a (1)H MRS study.
Schizophr Res 2015 Feb;161(2-3):252-60. Epub 2014 des 24
PMID: 25542859
Auditory verbal hallucinations reflect stable auditory attention deficits: a prospective study.
Cogn Neuropsychiatry 2015;20(1):81-94.
PMID: 25384552
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.
Front Psychiatry 2014;5():159. Epub 2014 nov 18
PMID: 25477825
Cognitive changes in patients with acute phase psychosis--effects of illicit drug use.
Psychiatry Res 2014 Dec 30;220(3):818-24. Epub 2014 sep 8
PMID: 25240944
Dichotic listening, executive functions and grey matter cortical volume in patients with schizophrenia and healthy controls.
Scand J Psychol 2013 Oct 9. Epub 2013 okt 9
PMID: 24117463
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.
BMC Psychiatry 2013;13():241. Epub 2013 sep 30
PMID: 24079855
Failure of attention focus and cognitive control in schizophrenia patients with auditory verbal hallucinations: evidence from dichotic listening.
Schizophr Res 2013 Jul;147(2-3):301-9. Epub 2013 mai 9
PMID: 23664588
The role of the primary auditory cortex in the neural mechanism of auditory verbal hallucinations.
Front Hum Neurosci 2013;7():144. Epub 2013 apr 24
PMID: 23630479
Prospective and concurrent correlates of emotion perception in psychotic disorders: a naturalistic, longitudinal study of neurocognition, affective blunting and avolition.
Scand J Psychol 2013 Jun;54(3):261-6. Epub 2013 mar 1
PMID: 23448554
Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
Eur Psychiatry 2013 Mar;28(3):174-84. Epub 2011 des 6
PMID: 22153730
Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
BMC Psychiatry 2012 Dec;12(1):221. Epub 2012 des 5
PMID: 23216941
An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.
Front Psychiatry 2012;3():94. Epub 2012 okt 30
PMID: 23115554
Childhood trauma in schizophrenia spectrum disorder as compared to other mental health disorders
Psychosis 2016 epub 2016 july 29
Cogn changes in non-affective psych the first 4-6 weeks after adm to a psychiatr acute ward: effects of substance use.
Schizophrenia Bulletin, supplement, 2013
Clinical differences in acute-phase non-affective psychotic disorders with and without substance use.
2012. Schizophrenia Research, 136, supplement 1, 199. Abstract.
Neurocognitive functions recover from acute phase to three month-follow up in patients with non-affective psychotic disorders.
2012. Journal of the International NeuropsycNeuropsychological Society, 18, supplement 2, 87. Abstract.
Cogn changes in non-affective psychosis the first 4-6 weeks after adm to a psychiatric acute ward: effects of substance use.
In Press. Cognitive changes in non-affective psychosis the first 4-6 weeks after admission to a psychiatric acute ward: effects of substance use. Schizophrenia Bulletin, supplement. Abstract.
Når cannabis gir psykose
Hubro, 3(18), 56-57
Nyere nevrobiologisk tenkning: Implikasjoner for psykoterapi ved psykoser
Dialog, 21, 53-60
Kan kunnskap om hjernen ved psykose ha klinisk nytteverdi?
BestPractise, 7, 8-11
Hjerneforskning har klinisk nytteverdi
Tidsskrift for Norsk Psykologforening, 48, 696-697
Den pragmatiske nytten av hjerneforskning
Tidsskrift for Norsk Psykologforening, 48, 919-929
Cannabis use and brain functioning in schizophrenia: An fMRI study.
Schizophrenia Bulletin, 37, 144-145
Lower neurocognitive vulnerability in schizophrenia with a history of cannabis abuse
Akuttpsykiatrisk forskningsseminar, 10. nasjonale konferanse i akuttpsykiatri abstraktbok
Meir amfetamin, fleire psykotiske
Stavanger Aftenblad, 28.10.11
Cannabis use in non-affective psychoses : relationship to age at onset, cognitive functioning and social cognition
- Disputert:
- september 2016
- Hovedveileder:
- Else-Marie Løberg
- Tor Ketil Larsen Medveileder
- Erik Johnsen Medveileder
- Siri Helle Ph.d.-kandidat
- Else-Marie Løberg Prosjektleder
- Sverre Nesvåg Prosjektdeltaker
- Kenneth Hugdahl Medveileder
- Rune Andreas Kroken Prosjektdeltaker
- Inge Joa Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest